相关实验视频
Updated: Jun 2, 2025

09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.4K
脂质代谢在认知障碍中的作用
Meifang Xu1,2, Liyuan Wang1, Yun Meng2
1Second Medical University, School of Clinical Medicine, Weifang Shandong Province, China.
Arquivos de neuro-psiquiatria
|January 15, 2025
概括
代谢障碍,特别是脂质代谢异常,在阿尔茨海默病,糖尿病认知障碍和血管痴呆症中显著影响认知障碍的进展. 向脂质运输蛋白APOE为这些疾病提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 代谢障碍 代谢障碍 代谢障碍
- 神经退行性疾病 神经退行性疾病
背景情况:
- 阿尔茨海默病 (AD),糖尿病认知障碍 (DCI) 和血管痴呆症 (VD) 是严重认知障碍的主要原因.
- 代谢障碍,特别是脂质代谢失调,越来越多地被认为是认知能力下降的关键因素.
- 脂质新陈代谢对大脑平衡至关重要,影响神经元结构,功能和信号传递.
研究的目的:
- 讨论脑脂代谢障碍在认知障碍进展中的作用.
- 探索针对认知障碍的阿波利波蛋白E (APOE) 的治疗潜力.
- 检查与脂质代谢相关的AD,DCI和VD的常见病原发生,包括Aβ沉积,高酸化和胰岛素抵抗.
主要方法:
- 关于脂质代谢和认知障碍的当前文献的综述.
- 分析脂质失调影响神经病理学的机制.
- 研究APOE在脂质运输和疾病发病过程中的作用.
主要成果:
- 异常的脂质代谢可以通过影响粉样β (Aβ) 沉积,高酸化和胰岛素抵抗来加剧认知障碍.
- 脂质失调影响神经元膜完整性,神经递质功能和突触可塑性.
- 作为一种关键的脂质载体,APOE与AD,DCI和VD的发展和进展有关.
结论:
- 准脂质代谢是一个有前途的治疗途径,用于认知障碍.
- 了解脂质平衡与神经退行过程之间的复杂关系对于开发有效治疗非常重要.
- 针对APOE的疗法需要进一步研究,以管理与代谢障碍相关的认知衰退.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95
Overview of Lipid Metabolism
997
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
997
Role of Neurotransmitters in Memory
413
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
413
Alzheimer's Disease: Overview
440
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
440
Cognitive Development During Adulthood
49
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
49
Alzheimer's Disease: Treatment
161
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
161

